User 414457

Big Pharma Maintains Illusion of Innovation

The "pharma spending is a tradeoff between R&D and marketing" argument is a red herring. Marketing has one purpose and one purpose only, to bring in more revenue than is spent. Marketing spend is constantly indexed to return on investment, and if it's not generating sufficient ROI, it is cut. And what is said revenue used for? R&D, or rewards to shareholders for investing in the company.
Please, people, let's not just parrot leftie applause lines.